Company profile
Home | GSK
At GSK, we unite science, technology and talent to get ahead of disease together
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
CH01 | Transaction MzQzNjY4MTEwNmFkaXF6a2N4
Published 23 Sep 2024 06:26
CH03 | Transaction MzQzNjY4MTA4MWFkaXF6a2N4
Published 23 Sep 2024 06:19
CH01 | Transaction MzQzNjAzMDYxOGFkaXF6a2N4
Published 17 Sep 2024 06:38
PSC05 | Transaction MzQzNTI0NDMxMGFkaXF6a2N4
Published 02 Oct 2024 01:57
CH02 | Transaction MzQzNTI0NDM2NGFkaXF6a2N4
Published 11 Sep 2024 07:03
CS01 | Transaction MzQzMjM0MjIzNWFkaXF6a2N4
Published 15 Aug 2024 10:50
AA | Transaction MzQzMTE5ODI0MGFkaXF6a2N4 | Paper/PDF filed
Published 10 Aug 2024 07:57
Company registered at Companies House
1 Oct 2009 to 31 Mar 2012
Liquid Dispensing Technology (LDT) is a novel manufacturing platform technology developed by GlaxoSmithKline to aid in the rapid development and manufacture of low-dose and/or highly potent products. Drug product is prepared in a liquid form and then applied to placebo tablets. The solution preparation significantly reduces the potential risk for operator...
